Data is not available at this time.
Optima Health plc operates in the occupational health and wellbeing sector, providing specialized services such as Engagement and Wellbeing, mental health support, and musculoskeletal care. The company serves businesses seeking to enhance employee health and productivity, positioning itself as a key player in the UK's corporate healthcare market. With a history dating back to 1947, Optima Health leverages its long-standing expertise to deliver tailored solutions that address workplace health challenges. The company’s focus on preventative and diagnostic services differentiates it from general healthcare providers, allowing it to capture niche demand. Its headquarters in Sheffield underscores its regional presence while serving a national client base. The occupational health sector is increasingly vital as employers prioritize employee wellbeing, giving Optima Health a strategic advantage in a growing market. The company’s integrated service model combines physical and mental health support, aligning with broader corporate trends toward holistic employee care.
Optima Health reported revenue of £110.9 million for FY 2024, reflecting its established market presence. However, the company recorded a net loss of £1.1 million, with diluted EPS at -0.012 GBp, indicating profitability challenges. Operating cash flow was positive at £12.8 million, suggesting effective working capital management, while capital expenditures remained modest at £0.4 million, highlighting disciplined investment.
The company’s negative net income and EPS point to subdued earnings power in the near term. However, its ability to generate positive operating cash flow demonstrates resilience in core operations. With limited capital expenditures, Optima Health maintains a lean operational structure, though its profitability metrics require improvement to enhance capital efficiency and shareholder returns.
Optima Health holds £8.2 million in cash and equivalents, providing liquidity for near-term obligations. Total debt stands at £12.5 million, indicating a manageable leverage position. The absence of dividends suggests a focus on reinvestment or debt reduction. The balance sheet reflects moderate financial health, with sufficient liquidity but room for stronger profitability to bolster long-term stability.
Revenue growth trends are not explicitly detailed, but the company’s focus on occupational health aligns with rising corporate demand for wellbeing services. Optima Health does not currently pay dividends, prioritizing operational reinvestment. Future growth may hinge on expanding service offerings or improving margins in a competitive healthcare landscape.
With a market capitalization of approximately £166.9 million, Optima Health trades at a modest valuation relative to its revenue. The negative earnings and lack of dividends may weigh on investor sentiment, though its niche market position offers potential upside if profitability improves. The beta of 0.65 suggests lower volatility compared to the broader market.
Optima Health benefits from its specialized focus on occupational health, a sector with growing relevance. Its long-standing reputation and integrated service model provide competitive differentiation. However, achieving profitability remains a key challenge. The outlook depends on its ability to scale efficiently and capitalize on corporate health trends, potentially through strategic partnerships or service innovation.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |